BioShares Biotechnology Clinical Trials ETF Forecast
About Chart
Golden Star
The Golden Star is a refined bullish signal based on the Golden Cross, developed by Jim Stromberg, incorporating additional time frame-specific moving averages and precise price line crossings. This signal is effective for liquid stocks, highlighting short-term upward momentum.
Death Star
The Death Star, developed by Jim Stromberg, is the bearish counterpart to the Golden Star, serving as a sell signal. It is triggered by specific moving average crossings on the price line, indicating a likely prolonged decline in the stock.
Golden Cross
The Golden Cross is a bullish signal where the short-term moving average crosses above the long-term moving average, indicating potential upward momentum.
Death Cross
The Death Cross is a bearish signal where the short-term moving average crosses below the long-term moving average, indicating potential downward momentum.
Pivot Bottom
A Pivot Bottom is a significant low point identified by algorithms developed by StockInvest.us. While it may indicate a short-term directional change, it does not necessarily imply a complete trend reversal. Pivot Bottoms are marked as green circles on the price line.
Pivot Top
A Pivot Top represents a significant high point identified by algorithms developed by StockInvest.us. Similar to Pivot Bottoms, it may suggest a short-term directional change within the main trend, rather than a full trend reversal. Pivot Tops are marked as red circles on the price line.
RSI Oversold
RSI oversold indicates that a stock has declined significantly and may be undervalued, potentially presenting a buying opportunity. This condition is marked by a green line on the chart but should be confirmed with other indicators before taking action.
RSI Overbought
RSI overbought suggests that a stock has risen rapidly and may be due for a pullback. It is marked by a red line on the chart, signaling increased risk. This doesn’t necessarily mean it’s time to sell, but it’s important to monitor closely.
Accumulated Volume
The bars indicate how much stock has been traded on each price during the chart period.
Buy Signal (MA)
Buy Signal from Moving Average: Indicates potential upward movement.
Sell Signal (MA)
Sell Signal from Moving Average: Indicates potential downward movement.
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
AI Analysis of BBC
| Stock Analysis |
|
| Risk Assessment |
|
| Trading Strategy |
|
BioShares Biotechnology Clinical Trials ETF price ended at $27.27 on Thursday, after losing 0.94%
(Updated on Oct 03, 2024)
Hold candidate since Oct 02, 2024
Loss -0.94%
The BioShares Biotechnology Clinical Trials ETF price fell by -0.94% on the last day (Thursday, 3rd Oct 2024) from $27.53 to $27.27. During the last trading day the ETF fluctuated 0.0367% from a day low at $27.26 to a day high of $27.27. The price has fallen in 6 of the last 10 days and is down by -7.78% for this period. Volume fell on the last day along with the ETF, which is actually a good sign as volume should follow the ETF. On the last day, the trading volume fell by -2 thousand shares and in total, 426 shares were bought and sold for approximately $11.62 thousand.
The ETF is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect BioShares Biotechnology Clinical Trials ETF with a 90% probability to be traded between $26.25 and $31.02 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and ETF seldom manage to go directly from the bottom of a trend up to the top. ETF turning up in the middle of a horizontal trend are therefore considered to be potential runners.
BBC Signals & Forecast
There are few to no technical positive signals at the moment. The BioShares Biotechnology Clinical Trials ETF holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $27.68 and $27.83. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, September 19, 2024, and so far it has fallen -7.78%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this ETF may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. The ETF had a Golden Star Signal on Monday, June 03, 2024 in the long-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Golden Star 12 Months
The ETF had a Golden Star Signal on Monday, June 03, 2024 in the long-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the ETF in question.
Support, Risk & Stop-loss for BioShares Biotechnology Clinical Trials ETF
BioShares Biotechnology Clinical Trials finds support from accumulated volume at $26.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This ETF has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the ETF moved $0.0100 between high and low, or 0.0367%. For the last week the ETF has had daily average volatility of 0.584%.
Our recommended stop-loss: $25.71 (-5.72%) (This ETF has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 10 days ago.)
Trading Expectations (BBC) For The Upcoming Trading Day Of Friday 4th
For the upcoming trading day on Friday, 4th we expect BioShares Biotechnology Clinical Trials Fund to open at $27.27, and during the day (based on 14 day Average True Range), to move between $26.75 and $27.79, which gives a possible trading interval of +/-$0.521 (+/-1.91%) up or down from last closing price. If BioShares Biotechnology Clinical Trials Fund takes out the full calculated possible swing range there will be an estimated 3.82% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $27.79 (1.91%) than the support at $26.09 (4.35%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is BioShares Biotechnology Clinical Trials Fund ETF A Buy?
BioShares Biotechnology Clinical Trials holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
-0.021
Hold/Accumulate
Unchanged
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
Predicted Fair Opening Price
Predicted fair opening price on October 4, 2024 - $27.27 ( 0.0122%). The predicted opening price is based on yesterday's movements between high, low, and closing price.Trading levels for BBC
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 27.28 | 0.0244% |
| R2 | 27.27 | 0.0104% |
| R1 | 27.27 | 0.0018% |
| Price | 27.27 | |
| S1 | 27.26 | -0.0262% |
| S2 | 27.26 | -0.0349% |
| S3 | 27.26 | -0.0489% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 29.11 | 6.75% |
| R2 | 28.33 | 3.89% |
| R1 | 27.79 | 1.91% |
| Price | 27.27 | |
| S1 | 26.09 | -4.35% |
| S2 | 25.39 | -6.89% |
| S3 | 24.75 | -9.25% |
BBC Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Dec 20, 2023 | Dec 20, 2023 | Dec 20, 2023 | $0.0820 | 0.369% |
| 2 | Dec 19, 2017 | Dec 20, 2017 | Dec 27, 2017 | $0.297 | 1.04% |
| 3 | Dec 21, 2015 | Dec 21, 2015 | Dec 29, 2015 | $0.147 | 0.498% |
FAQ
Click here for our free guide on how to buy BioShares Biotechnology Clinical Trials Fund ETF.
